THYMUS CARCINOMA

Clinical trials for THYMUS CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new THYMUS CARCINOMA trials appear

Sign up with your email to follow new studies for THYMUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New immune therapy tested for rare, Hard-to-Treat cancer

Disease control Recruiting now

This study is testing an immunotherapy drug called ivonescimab for people with advanced thymic carcinoma, a rare cancer, who have already tried other treatments. The main goal is to see if the drug helps shrink tumors and is safe for patients. Participants will receive the drug t…

Matched conditions: THYMUS CARCINOMA

Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

THYMUS CARCINOMA

Get alerted when new THYMUS CARCINOMA trials appear

New immune therapy tested for rare, Hard-to-Treat cancer